Login to Your Account

Dream police: Engeneic nano bid enlists bacteria in one-two cancer punch

By Randy Osborne
Staff Writer

Tuesday, July 14, 2015
Nanocell firm Engeneic Ltd. started using cancer immunotherapy in its unique way "before anyone else, because we have bacterially derived particles," Managing Director Jennifer MacDiarmid told BioWorld Today.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription